Company Filing History:
Years Active: 2001
Title: John Alfred Slack: Innovator in Pharmaceutical Prodrugs
Introduction
John Alfred Slack is a notable inventor based in Solihull, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that enhance drug solubility and efficacy.
Latest Patents
John Alfred Slack holds a patent for "Analogues or derivatives of quercetin (prodrugs)." This innovative work focuses on novel carbamate ester analogues or derivatives of quercetin, which exhibit enhanced aqueous solubility. These compounds are especially suitable for use as biodegradable prodrugs in pharmaceutical compositions formulated for clinical use. He has 1 patent to his name.
Career Highlights
Slack is associated with Cobra Therapeutics Limited, where he applies his expertise in pharmaceutical development. His work has the potential to significantly impact the effectiveness of drug therapies.
Collaborations
Throughout his career, John has collaborated with esteemed colleagues such as Bernard Thomas Golding and Roger John Griffin. These partnerships have fostered innovation and advancement in their shared field.
Conclusion
John Alfred Slack's contributions to pharmaceutical science, particularly through his patented work on quercetin derivatives, highlight his role as a key innovator in the industry. His ongoing efforts continue to pave the way for advancements in drug formulation and delivery.